Cargando…
Optimization Strategies Aimed to Increase the Efficacy of Helicobacter pylori Eradication Therapies with Quinolones
H. pylori infection is the main cause of gastritis, gastroduodenal ulcer disease, and gastric cancer. Fluoroquinolones such as levofloxacin, or more recently moxifloxacin or sitafloxacin, are efficacious alternatives to standard antibiotics for H. pylori eradication. The aim of the present review is...
Autor principal: | Gisbert, Javier P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663000/ https://www.ncbi.nlm.nih.gov/pubmed/33147814 http://dx.doi.org/10.3390/molecules25215084 |
Ejemplares similares
-
Quinolone-Containing Therapies in the Eradication of Helicobacter pylori
por: Chuah, Seng-Kee, et al.
Publicado: (2014) -
Quinolone-Based Third-Line Therapy for Helicobacter pylori
Eradication
por: Nishizawa, Toshihiro, et al.
Publicado: (2009) -
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
por: Gisbert, Javier P, et al.
Publicado: (2012) -
Efficacy of Vonoprazan for Helicobacter pylori Eradication
por: Kiyotoki, Shu, et al.
Publicado: (2019) -
Rescue Therapy for Helicobacter pylori Infection 2012
por: Gisbert, Javier P.
Publicado: (2012)